Alphabet-A
GOOGL
Alphabet-C
GOOG
Tesla
TSLA
Meta Platforms
META
Apple
AAPL
US Stock MarketDetailed Quotes
ETON Eton Pharmaceutical
- 12.040
- -0.230-1.87%
Close Dec 10 16:00 ET
- 12.040
- 0.0000.00%
Post 20:01 ET
311.07MMarket Cap-57333P/E (TTM)
12.610High11.640Low152.55KVolume12.270Open12.270Pre Close1.85MTurnover0.70%Turnover RatioLossP/E (Static)25.84MShares13.98052wk High19.45P/B261.12MFloat Cap3.03052wk Low--Dividend TTM21.69MShs Float13.980Historical High--Div YieldTTM7.91%Amplitude1.950Historical Low12.102Avg Price1Lot Size
Eton Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 238.14%2.95M | -82.33%1.26M | -59.75%-2.47M | 41.36%6.82M | -86.37%387K | 151.26%873K | 188.62%7.1M | -226.57%-1.55M | 202.12%4.82M | 155.50%2.84M |
| Net income from continuing operations | 208.29%627K | -166.70%-3.04M | 69.51%-811K | 89.62%-936K | -347.37%-2.26M | 80.99%-579K | 392.62%4.56M | 50.09%-2.66M | -361.43%-9.02M | -12.22%912K |
| Depreciation and amortization | 45.55%278K | 51.74%261K | 18.31%252K | -49.21%901K | 28.97%325K | 12.35%191K | -85.31%172K | 17.68%213K | 283.98%1.77M | 83.94%252K |
| Other non cash items | -2.50%39K | -16.90%59K | -13.79%25K | -7.87%117K | -174.19%-23K | 33.33%40K | 136.67%71K | -19.44%29K | -14.19%127K | -18.42%31K |
| Change In working capital | 161.91%1.29M | 106.86%3.14M | -137,900.00%-2.76M | -53.44%3.6M | 109.62%1.59M | 154.40%491K | -0.13%1.52M | -100.04%-2K | 224.34%7.72M | 110.55%759K |
| -Change in receivables | -74.45%-717K | -201.43%-633K | 18.88%-829K | -143.08%-1.56M | 123.73%84K | 38.10%-411K | -452.63%-210K | -121.86%-1.02M | 166.73%3.62M | 93.04%-354K |
| -Change in inventory | 155.32%130K | 165.96%250K | -1,272.50%-1.41M | -4,957.14%-354K | 284.21%140K | -570.00%-235K | -1,704.76%-379K | 200.00%120K | -101.01%-7K | 64.81%-76K |
| -Change in prepaid assets | -148.77%-159K | 8.19%251K | -58.64%79K | -91.54%161K | -159.03%-588K | 7.95%326K | -73.21%232K | -80.12%191K | 285.38%1.9M | 69.45%-227K |
| -Change in payables and accrued expense | 150.55%2.03M | 74.48%3.27M | -185.05%-603K | 142.10%5.35M | 38.06%1.96M | 60.59%811K | 163.43%1.87M | 267.61%709K | 586.56%2.21M | 223.24%1.42M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 238.14%2.95M | -82.33%1.26M | -59.75%-2.47M | 41.36%6.82M | -86.37%387K | 151.26%873K | 188.62%7.1M | -226.57%-1.55M | 202.12%4.82M | 155.50%2.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -1.88M | 72.20%-775K | -6,358.33%-775K | 0 | 0 | 0 | -8.95%-2.79M | 99.63%-12K |
| Net PPE purchase and sale | --0 | --0 | ---14K | --0 | --0 | --0 | --0 | --0 | -105.50%-38K | -200.00%-12K |
| Net intangibles purchase and sale | --0 | --0 | ---1.87M | 71.82%-775K | ---775K | --0 | --0 | --0 | 15.38%-2.75M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---1.88M | 72.20%-775K | -6,358.33%-775K | --0 | --0 | --0 | -8.95%-2.79M | 99.63%-12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -4.34%-385K | 11.84%-216K | -671.43%-378K | -614.18%-957K | -396.97%-294K | -1,154.29%-369K | -309.40%-245K | 87.27%-49K | -134.27%-134K | 45.59%99K |
| Net issuance payments of debt | 0.00%-385K | 0.00%-385K | ---385K | -200.00%-1.16M | ---385K | ---385K | ---385K | --0 | -156.67%-385K | --0 |
| Proceeds from stock option exercised by employees | --0 | 20.71%169K | -94.70%7K | -21.12%198K | -190.91%-90K | -54.29%16K | 19.66%140K | --132K | -53.60%251K | 45.59%99K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---181K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -4.34%-385K | 11.84%-216K | -671.43%-378K | -614.18%-957K | -396.97%-294K | -1,154.29%-369K | -309.40%-245K | 87.27%-49K | -134.27%-134K | 45.59%99K |
| Net cash flow | ||||||||||
| Beginning cash position | -17.95%17.69M | 13.24%16.66M | 31.17%21.39M | 13.18%16.31M | 64.97%22.07M | 26.52%21.57M | -3.42%14.71M | 13.18%16.31M | -32.35%14.41M | -41.09%13.38M |
| Current changes in cash | 409.33%2.57M | -84.85%1.04M | -196.37%-4.73M | 167.67%5.08M | -123.30%-682K | 113.74%504K | 277.44%6.86M | -294.05%-1.6M | 127.57%1.9M | 135.25%2.93M |
| End cash Position | -8.20%20.26M | -17.95%17.69M | 13.24%16.66M | 31.17%21.39M | 31.17%21.39M | 64.97%22.07M | 26.52%21.57M | -3.42%14.71M | 13.18%16.31M | 13.18%16.31M |
| Free cash flow | 238.14%2.95M | -82.33%1.26M | -181.33%-4.36M | 197.10%6.04M | -113.72%-388K | 123.58%873K | 317.82%7.1M | -228.15%-1.55M | 125.48%2.03M | 133.78%2.83M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.